人输卵管灌洗液蛋白质组在胚胎转运期的特征揭示优化植入前胚胎培养的候选蛋白
本研究对26名健康女性在月经周期不同阶段采集的输卵管灌洗液进行无标记质谱蛋白质组分析,比较早期分泌期与月经期的差异。结果发现74个差异表达蛋白,富集于糖代谢、氧化应激和细胞存活相关通路,其中14-3-3 zeta在早期分泌期显著升高。在小鼠胚胎实验中,测试浓度下补充14-3-3 zeta未显著改善囊胚发育率。
要点
- 早期分泌期人输卵管灌洗液蛋白质组与月经期相比有74个差异蛋白。
- 差异蛋白富集于糖酵解、氧化还原稳态和14-3-3 zeta介导的信号通路。
- 小鼠胚胎培养中补充14-3-3 zeta未显著提高囊胚发育率。
核心结论
- 人输卵管灌洗液蛋白质组在早期分泌期呈现独特特征,鉴定出可用于优化胚胎培养的候选蛋白。
研究设计与样本
- 对26名健康女性开放显微输卵管吻合术采集的远端输卵管灌洗液进行蛋白质组分析,按月经周期分期比较。
- 小鼠胚胎实验:从超排野生型C57BL/6雌鼠收集482枚单细胞胚胎,微滴培养5天评估囊胚发育。
主要发现
- 早期分泌期与月经期比较发现74个差异表达蛋白,富集于碳水化合物代谢、氧化应激和细胞存活相关通路。
- 衔接调节蛋白14-3-3 zeta是早期分泌期显著增加的蛋白之一。
- 在测试浓度下,胚胎培养基补充14-3-3 zeta未显著改善小鼠囊胚发育。
关键数值与推荐
- 早期分泌期与月经期人输卵管灌洗液蛋白质组比较:74个差异表达蛋白。
- 小鼠胚胎实验:单细胞胚胎N=482,培养5天评估囊胚发育率。
临床怎么用
- 本研究首次描述人输卵管灌洗液蛋白质组在月经周期中的变化,为优化IVF培养基提供候选蛋白。
- 补充14-3-3 zeta在测试浓度下未显著改善小鼠囊胚发育,提示需进一步筛选其他候选蛋白。
局限性
- 细胞培养为体外近似,不能完全代表体内环境。
- 胚胎培养基变更需在人体使用前进行严格的临床前安全性测试。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are there phase-specific changes in the early secretory (ES) phase human tubal lavage proteome that can inform and potentially optimize IVF culture media? SUMMARY ANSWER: The human tubal lavage proteome during the ES phase relative to the menstrual phase reveals substantial differential protein abundance in pathways such as glycolysis, redox homeostasis and activation of 14-3-3 zeta-mediated signaling. WHAT IS KNOWN ALREADY: The Fallopian tube is uniquely suited to the development of the preimplantation embryo as it transits the tube during the ES phase of the menstrual cycle. Euploid cleavage-stage embryo arrest may reflect incomplete recapitulation of in-vivo conditions by current media formulations. STUDY DESIGN, SIZE, DURATION: Proteome-wide analysis of distal tubal lavage specimens collected from 26 healthy women undergoing open microtubal anastomosis surgery from January 2013 to January 2018 was performed. Specimens were grouped by menstrual cycle phase in order to analyze phase-specific differences in protein abundance. For the murine embryo assay, single-cell embryos (N = 482) were collected from superovulated wild type C57BL/6 female mice and cultured in microdrops over 5 days for the assessment of blastocyst development. PARTICIPANTS/MATERIALS, SETTING, METHODS: Human tubal lavage specimens were processed for label-free mass spectrometry. Reported menstrual cycle day was confirmed by measuring serum hormones. Key protein targets in the ES phase were validated via immunoblot. The ES phase-specific increase in 14-3-3 zeta protein was confirmed via ELISA of conditioned media obtained from primary human Fallopian tube epithelial cell culture. A murine embryo assay was performed to investigate the impact of graduated concentrations of 14-3-3 zeta on the blastocyst development rate. MAIN RESULTS AND THE ROLE OF CHANCE: Comparison of the ES and menstrual phase human tubal lavage proteomes revealed 74 differentially expressed proteins with enrichment of pathways and biological processes involved in the regulation of carbohydrate metabolism, oxidative stress and cell survival. The adapter-regulator protein 14-3-3 zeta was among the most significantly increased in the ES phase. Supplementation of embryo culture media with 14-3-3 zeta at concentrations tested did not significantly improve the murine blastocyst development. LIMITATIONS, REASONS FOR CAUTION: Although select associations were recapitulated in the conditioned media from sex steroid exposed primary human tubal epithelial cells, cell culture represents an in-vitro approximation. Changes to embryo culture media, such as protein supplementation, must undergo rigorous preclinical safety testing prior to adoption for human use. WIDER IMPLICATIONS OF THE FINDINGS: This study represents the first description of the human Fallopian tube lavage proteome across the menstrual cycle, revealing a unique proteomic signature during the ES phase. Although supplementation of culture media with 14-3-3 zeta at appropriate concentrations showed no significant impact on the murine blastocyst development rate, other biologically plausible candidate proteins for individual or high throughput testing strategies are identified. STUDY FUNDING/COMPETING INTEREST(S): This work was funded in part by an Army Medical Department Advanced Medical Technology Initiative grant from the United States Army Medical Research and Materiel Command's Telemedicine and Advanced Technology Research Center. There are no competing interests. TRIAL REGISTRATION NUMBER: N/A.
引用
- Fujii DT, Yohannes E, Por ED, et al. The proteome of human Fallopian tube lavages during the phase of embryo transit reveals candidate proteins for the optimization of preimplantation embryo culture. Hum Reprod. 2021. PMID: 33355349. doi:10.1093/humrep/deaa333
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。